Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Rivaroxaban may cause hair loss.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Ozenoxacin reduces sebum production, helping manage acne.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Minoxidil metabolizes similarly in monkeys and humans, but differently in dogs and rats.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The treatment cleared psoriasis in some patients but caused side effects in most.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Topical Ruxolitinib may safely treat severe hair loss.

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.